| Literature DB >> 33095384 |
Jin Cao1,2, Shubhmita Bhatnagar2,3, Jiawei Wang2,4, Xueyong Qi1, Swayam Prabha2,5, Jayanth Panyam6,7.
Abstract
Cancer stem cells (CSCs) are a small proportion of cancer cells with high tumorigenic activity, self-renewal ability, and multilineage differentiation potential. Standard anti-tumor therapies including conventional chemotherapy, radiation therapy, and molecularly targeted therapies are not effective against CSCs, and often lead to enrichment of CSCs that can result in tumor relapse. Therefore, it is hypothesized that targeting CSCs is key to increasing the efficacy of cancer therapies. In this review, CSC properties including CSC markers, their role in tumor growth, invasiveness, metastasis, and drug resistance, as well as CSC microenvironment are discussed. Further, CSC-targeted strategies including the use of targeted drug delivery systems are examined.Entities:
Keywords: Anti-tumor therapy; Cancer biology; Cancer stem cells (CSCs); Drug delivery system; Drug-resistance
Mesh:
Substances:
Year: 2020 PMID: 33095384 PMCID: PMC8062588 DOI: 10.1007/s13346-020-00863-9
Source DB: PubMed Journal: Drug Deliv Transl Res ISSN: 2190-393X Impact factor: 5.671